P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection
- PMID: 12046070
- PMCID: PMC4656421
- DOI: 10.3748/wjg.v8.i3.459
P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection
Abstract
Aim: To confirm if p53 mutation could be a routine predictive marker for the prognosis of hepatocellular carcinoma (HCC) patients.
Methods: Two hundreds and forty-four formalin-fixed paraffin-embedded tumor samples of the patients with HCC receiving liver resection were detected for nuclear accumulation of p53. The percent of P53 immunoreactive tumor cells was scored as 0 to 3+ in P53 positive region (<10% -, 10-30% +, 31-50% ++, >50% +++). Proliferating cell nuclear antigen (PCNA) and some clinicopathological characteristics, including patients' sex, preoperative serum AFP level, tumor size, capsule, vascular invasion (both visual and microscopic), and Edmondson grade were also evaluated.
Results: In univariate COX harzard regression model analysis, tumor size, capsule status, vascular invasion, and p53 expression were independent factors that were closely related to the overall survival (OS) rates of HCC patients. The survival rates of patients with 3+ for P53 expression were much lower than those with 2+ or + for P53 expression. Only vascular invasion (P<0.05) and capsule (P<0.01) were closely related to the disease-free survival (DFS) of HCC patients. In multivariate analysis, p53 overexpression (RI 0.5456, P<0.01) was the most significant factor associated with the OS rates of patients after HCC resection, while tumor size (RI 0.5209, P<0.01), vascular invasion (RI 0.5271, P<0.01) and capsule (RI-0.8691, P<0.01) were also related to the OS. However, only tumor capsular status was an independent predictive factor (P<0.05) for the DFS. No significant prognostic value was found in PCNA-LI, Edmondson's grade, patients' sex and preoperative serum AFP level.
Conclusion: Accumulation of p53 expression, as well as tumor size, capsule and vascular invasion, could be valuable markers for predicting the prognosis of HCC patients after resection. The quantitative immunohistochemical scoring for P53 nuclear accumulation might be more valuable for predicting prognosis of patients after HCC resection than the common qualitative analysis.
Similar articles
-
Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.World J Gastroenterol. 2005 May 14;11(18):2709-13. doi: 10.3748/wjg.v11.i18.2709. World J Gastroenterol. 2005. PMID: 15884108 Free PMC article.
-
Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.J Gastrointestin Liver Dis. 2008 Dec;17(4):411-7. J Gastrointestin Liver Dis. 2008. PMID: 19104702
-
Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649. World J Gastroenterol. 2015. PMID: 26074703 Free PMC article.
-
Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.Jpn J Radiol. 2019 Mar;37(3):191-208. doi: 10.1007/s11604-019-00817-3. Epub 2019 Feb 2. Jpn J Radiol. 2019. PMID: 30712167 Review.
-
The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.Clin Exp Med. 2023 Sep;23(5):1515-1536. doi: 10.1007/s10238-022-00934-w. Epub 2022 Nov 7. Clin Exp Med. 2023. PMID: 36342581 Review.
Cited by
-
The prognostic molecular markers in hepatocellular carcinoma.World J Gastroenterol. 2002 Jun;8(3):385-92. doi: 10.3748/wjg.v8.i3.385. World J Gastroenterol. 2002. PMID: 12046056 Free PMC article. Review.
-
Precision medicine: In need of guidance and surveillance.World J Gastroenterol. 2017 Jul 28;23(28):5045-5050. doi: 10.3748/wjg.v23.i28.5045. World J Gastroenterol. 2017. PMID: 28811702 Free PMC article.
-
Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.Tumour Biol. 2014 Jul;35(7):7163-75. doi: 10.1007/s13277-014-1874-4. Epub 2014 Apr 25. Tumour Biol. 2014. PMID: 24763823
-
Targeting the HGF-cMET Axis in Hepatocellular Carcinoma.Int J Hepatol. 2013;2013:341636. doi: 10.1155/2013/341636. Epub 2013 Mar 31. Int J Hepatol. 2013. PMID: 23606971 Free PMC article.
-
Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.Chin J Cancer Res. 2011 Dec;23(4):245-53. doi: 10.1007/s11670-011-0245-6. Chin J Cancer Res. 2011. PMID: 23359751 Free PMC article.
References
-
- Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29. - PubMed
-
- Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin. 2001;51:15–36. - PubMed
-
- Tang Z, Qin L, Wang X, Zhou G, Liao Y, Weng Y, Jiang X, Lin Z, Liu K, Ye S. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness. Chin Med J (Engl) 1998;111:313–318. - PubMed
-
- Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous